J
JLK Inc
KOSDAQ:322510
JLK Inc
KOSDAQ:322510
Price:
7 250
KRW
-3.33%
Market Closed
Market Cap:
₩185.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
JLK Inc
Note Receivable
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
JLK Inc
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
JLK Inc
KOSDAQ:322510
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
Note Receivable
₩15.7B
|
CAGR 3-Years
181%
|
CAGR 5-Years
63%
|
CAGR 10-Years
88%
|
|
|
U
|
UBCare Co Ltd
KOSDAQ:032620
|
Note Receivable
₩2.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
Note Receivable
₩5.9m
|
CAGR 3-Years
2 351%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
e
|
ezCaretech Co Ltd
KOSDAQ:099750
|
Note Receivable
₩88.9m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lunit Inc
KOSDAQ:328130
|
Note Receivable
₩85.5m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
JLK Inc
Glance View
JLK, Inc. develops AI based data-driven diagnostic system that detects brain disease. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2019-12-11. The firm develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
Intrinsic Value
430.44
KRW
Overvaluation 94%
J
